Dedicated to addressing patients’ needs
Developing innovative medicines for the future while championing the production of generics and biosimilars
Teva Pharmaceuticals is a leading innovative biopharmaceutical company, enabled by a world-class generics business. From in-house innovation to strategic partnerships, we are persistent in the creation of innovative medications, generic medicines and biologics to increasing the accessibility and affordability of existing medicines.
Our commitment is to address a broad range of patient needs across various therapeutic areas in neuroscience and immunology, including central nervous system disorders, respiratory conditions, oncology, and pain management. To do so, we continually invest in research and development, and our robust pipeline reflects our dedication to bringing groundbreaking therapies to market.
Innovation at Teva: Pharmaceutical Research and Development
We follow the science to create the medicines needed today; driving the discovery and development of modern therapies.
Learn about R&D at Teva.
With a legacy of excellence and a forward-looking approach, our dedication to patient-centric care drives us to create treatments that meet current healthcare needs and anticipate future challenges. We maintain high standards in manufacturing and quality control, helping to ensure that every product meets the required levels of safety and efficacy.
Teva remains steadfast in our commitment to improving health outcomes and enhancing the quality of life for patients worldwide. Together, we are all in for better health.
Generic Medicines
Teva is a global leader in generic medicines, making essential treatments accessible and affordable.
Biosimilars
Biosimilar medicines match existing biologic medications, increasing accessibility to vital treatments.
Teva is relentlessly pursuing the development of hard-to-make complex generics and biosimilar medicines to provide at-scale solutions where they are needed most—tackling access and affordability barriers. Through a global network of capabilities, we are discovering, developing and delivering our innovative, generic and biosimilar medicines to unlock more possibilities for patient care, positioning our business for greater opportunity and greater impact.
Innovative Therapeutic Areas
Teva's innovative medicine pipeline and portfolio spans multiple therapeutic areas in neuroscience and immunology. We are innovating where it matters most to support better health outcomes.
If patients have a need, we’re already working to address it.
NPS-ALL-NP-01501 MARCH 2025
